-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Akili (NASDAQ:AKLI) Price Target Raised to $3.00
Akili (NASDAQ:AKLI) Price Target Raised to $3.00
Akili (NASDAQ:AKLI – Get Rating) had its price target boosted by Morgan Stanley from $2.00 to $3.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an "equal weight" rating on the stock. Morgan Stanley's price objective would suggest a potential upside of 115.83% from the company's previous close.
Several other equities analysts have also recently issued reports on the stock. Credit Suisse Group boosted their price target on shares of Akili from $4.00 to $4.50 and gave the company an "outperform" rating in a research report on Tuesday, November 15th. Bank of America initiated coverage on shares of Akili in a report on Friday, November 18th. They issued a "neutral" rating on the stock. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Akili presently has a consensus rating of "Moderate Buy" and a consensus target price of $3.75.
Get Akili alerts:Akili Stock Performance
AKLI stock opened at $1.39 on Wednesday. The company has a 50-day moving average price of $1.37. Akili has a 12-month low of $0.86 and a 12-month high of $37.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 12.27 and a current ratio of 12.27.
Akili (NASDAQ:AKLI – Get Rating) last released its quarterly earnings data on Monday, November 14th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.11). The business had revenue of $0.08 million for the quarter. Equities research analysts anticipate that Akili will post -2.33 earnings per share for the current fiscal year.Institutional Trading of Akili
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Tower Research Capital LLC TRC purchased a new position in Akili during the third quarter valued at $32,000. Longitude Cayman Ltd. bought a new position in Akili during the third quarter valued at $34,000. Northeast Financial Consultants Inc bought a new position in Akili during the third quarter valued at $128,000. YHB Investment Advisors Inc. lifted its position in Akili by 25.7% during the fourth quarter. YHB Investment Advisors Inc. now owns 116,430 shares of the company's stock valued at $130,000 after purchasing an additional 23,830 shares during the last quarter. Finally, Revelation Capital Management LLC bought a new position in Akili during the third quarter valued at $556,000. 77.97% of the stock is owned by hedge funds and other institutional investors.
Akili Company Profile
(Get Rating)
Akili, Inc, a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Featured Articles
- Get a free copy of the StockNews.com research report on Akili (AKLI)
- The Future Of E-Commerce: Analysis And New Data
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
Receive News & Ratings for Akili Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akili and related companies with MarketBeat.com's FREE daily email newsletter.
Akili (NASDAQ:AKLI – Get Rating) had its price target boosted by Morgan Stanley from $2.00 to $3.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an "equal weight" rating on the stock. Morgan Stanley's price objective would suggest a potential upside of 115.83% from the company's previous close.
Akili（纳斯达克股票代码：AKLI — 获取评级） Benzinga报道，摩根士丹利在周三向投资者发布的研究报告中将其目标股价从2.00美元上调至3.00美元。该公司目前对该股的评级为 “同等权重”。摩根士丹利的价格目标表明，与该公司之前的收盘价相比，潜在的上涨空间为115.83％。
Several other equities analysts have also recently issued reports on the stock. Credit Suisse Group boosted their price target on shares of Akili from $4.00 to $4.50 and gave the company an "outperform" rating in a research report on Tuesday, November 15th. Bank of America initiated coverage on shares of Akili in a report on Friday, November 18th. They issued a "neutral" rating on the stock. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Akili presently has a consensus rating of "Moderate Buy" and a consensus target price of $3.75.
其他几位股票分析师最近也发布了有关该股的报告。瑞士信贷集团在11月15日星期二的一份研究报告中将Akili股票的目标股价从4.00美元上调至4.50美元，并将该公司的评级定为 “跑赢大盘”。美国银行在11月18日星期五的一份报告中开始报道Akili的股票。他们对该股发布了 “中性” 评级。两名研究分析师对该股进行了持有评级，四位对该公司发布了买入评级。根据Marketbeat.com的数据，Akili目前的共识评级为 “适度买入”，共识目标价为3.75美元。
Akili Stock Performance
Akili 股票表现
AKLI stock opened at $1.39 on Wednesday. The company has a 50-day moving average price of $1.37. Akili has a 12-month low of $0.86 and a 12-month high of $37.58. The company has a debt-to-equity ratio of 0.11, a quick ratio of 12.27 and a current ratio of 12.27.
周三，AKLI股票开盘价为1.39美元。该公司的50天移动平均价格为1.37美元。Akili创下12个月低点0.86美元，12个月高点为37.58美元。该公司的债务与权益比率为0.11，速动比率为12.27，流动比率为12.27。
Institutional Trading of Akili
阿基里的机构交易
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Tower Research Capital LLC TRC purchased a new position in Akili during the third quarter valued at $32,000. Longitude Cayman Ltd. bought a new position in Akili during the third quarter valued at $34,000. Northeast Financial Consultants Inc bought a new position in Akili during the third quarter valued at $128,000. YHB Investment Advisors Inc. lifted its position in Akili by 25.7% during the fourth quarter. YHB Investment Advisors Inc. now owns 116,430 shares of the company's stock valued at $130,000 after purchasing an additional 23,830 shares during the last quarter. Finally, Revelation Capital Management LLC bought a new position in Akili during the third quarter valued at $556,000. 77.97% of the stock is owned by hedge funds and other institutional investors.
一些对冲基金和其他机构投资者最近修改了对该公司的持股。Tower Research Capital LLC TRC在第三季度在阿基里购买了一个价值32,000美元的新头寸。Longitude Cayman Ltd.在第三季度在Akili购买了一个价值34,000美元的新头寸。东北金融顾问公司在第三季度在阿基里购买了一个价值12.8万美元的新头寸。YHB Investment Advisors Inc.在第四季度将其在Akili的头寸提高了25.7％。YHB Investment Advisors Inc.在上个季度又购买了23,830股股票后，现在拥有该公司116,430股股票，价值13万美元。最后，Revelation Capital Management LLC在第三季度购买了阿基里的新头寸，价值55.6万美元。该股票的77.97％由对冲基金和其他机构投资者持有。
Akili Company Profile
阿基里公司简介
(Get Rating)
（获取评分）
Akili, Inc, a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
数字医学公司Akili, Inc开发认知障碍的数字疗法。它提供EndeavorRX，这是一种医生处方的基于视频游戏的治疗方法，旨在直接针对认知功能。该公司总部位于马萨诸塞州波士顿。
Featured Articles
精选文章
- Get a free copy of the StockNews.com research report on Akili (AKLI)
- The Future Of E-Commerce: Analysis And New Data
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
- Levi Strauss Is A Good Fit For Income Investors
- 3 Small Caps That Have Big Upside
- Mullen Automotive: The Good News, The Bad And The Ugly Outlook
- 免费获取 StockNews.com 关于 Akili (AKLI) 的研究报告的副本
- 电子商务的未来：分析和新数据
- 雪佛龙通过750亿美元的股票回购使股东感到高兴
- 李维·施特劳斯非常适合收入投资者
- 3 个有很大上升空间的小盘股
- Mullen Automotive：好消息、坏消息和丑陋前景
Receive News & Ratings for Akili Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akili and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Akili Daily 的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Akili及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧